3188 results for «702»
3188 results
PCI in stable CAD
14 Dec 2022 – From GulfPCR-GIM 2022
Study the two cases presented in this GulfPCR-GIM 2022 session to find out more about the importance of proper monitoring in detecting post-PCI complications and managing complex PCI and coronary stent loss.
Bifurcation lesion
14 Dec 2022 – From GulfPCR-GIM 2022
Among the 3 bifurcation lesion cases presented in this GulfPCR-GIM 2022 session, find out how to deliver a trapped guidewire, how to manage a live angioplasty that turned out to be a nightmare, and how to deal with a multivessel intervention with left main bifurcation and...
Ultrasound supported thrombolysis: a live-saving procedure in massive saddle pulmonary embolism
15 Dec 2022 – From GulfPCR-GIM 2022
Watch this GulfPCR-GIM 2022 session to learn how and why minimally invasive catheter directed thrombolytic therapy assisted by ultrasound can be effective and safe, even in massive pulmonary embolism with compromised RV function.
Left main multivessel disease and other coronary interventions
15 Dec 2022 – From GulfPCR-GIM 2022
This GulfPCR-GIM 2022 session will allow you to study a rare case of coronary artery dissection due to blunt chest trauma leading to myocardial infarction, the evolution from LAD to LMS stenting, the use of a mini-crush for a complex left main bifurcation, and much more!
Rapid-fire abstracts: Session 8
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: ultrasound-guided vs. conventional MANTA vascular closure device deployment after TAVR, novel aortic regurgitation quantification after Portico TAVI, mid-term outcome of TAVI using Myval transcatheter heart valve in severe bicuspid aortic stenosis, and...
Mitral annular calcification - From diagnosis to treatment
29 Nov 2022 – From PCR London Valves 2022
Focus on mitral annular calcification: from diagnosis to treatment, learn more about the prevalence and clinical importance of MAC, understand the challenges of different therapeutic approaches and discover the current results and perspectives on transcatheter mitral valve implantation in patients with MAC.
Rapid-fire abstracts: Session 9
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: impact of different aortic valve calcification pattern on the haemodynamic performance of self-expanding intra-annular transcatheter heart valve, device failure in bicuspid aortic stenosis following TAVR, the learning curve and clinical outcomes in...
Imaging for tricuspid valve interventions
29 Nov 2022 – From PCR London Valves 2022
Among the abstracts proposed in this PCR LV 2022 session, discover echocardiographic predictors of effective edge-to-edge repair in TR, TR in patients with continuous right ventricular pacing, TR and severe left-sided valvular heart disease, and much more!
Transcatheter edge-to-edge mitral valve repair step by step: from transseptal puncture to procedural success
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn how to perform a mitral transcatheter edge-to-edge repair procedure from start to finish, to learn more about currently available devices and which one to use in specific patients, and to understand how optimal procedural imaging and device steering determine the best...
TAVI challenges: session 4
29 Nov 2022 – From PCR London Valves 2022
This PCR LV 2022 session includes no less than 8 cases of TAVI complications, including TAVR in iatrogenic acute native pure aortic regurgitation, TAVI in a young patient after orthotopic liver retransplantation, or percutaneous treatment of a subaortic membrane using a self-expandable TAVR.
Mitral edge-to-edge repair: challenging cases
Watch an acute papillary muscle rupture with torrential mitral regurgitation, a transcatheter mitral edge-to-edge repair in recurrent mitral regurgitation after Alfieri stitch, and several other exciting challenging cases in this PCR LV 2022 session!
Surgical and transcatheter tricuspid intervention: state of the art - LIVE case
29 Nov 2022 – From PCR London Valves 2022
In this PCR London Valves 2022 session, follow 3 stunning case treatments:
- Part 1: Triscupid TEER (Live)
A 78-year-old male with a history of CABG (2015), PM-CRT (2015) and atrial fibrillation, presents a severe TR with an LVEF of 40%, preserved RV function and moderate pulmonary hypertension.
They performed...
PCR Live from London: episode 5
29 Nov 2022 – From PCR London Valves 2022
Consult this episode 5 of PCR Live from London to discover a presentation regarding simulation lab sessions, and learn more about the possible complications in TEER and their management.
Mitral and tricuspid patients are different from the TAVI population - Impact on clinical care
28 Nov 2022 – From PCR London Valves 2022
Consult this session to learn more about the different needs of mitral and tricuspid patients, to appreciate what optimal medical therapy really means and to improve your knowledge of the anticoagulant requirements for different patient populations.
Improving the equity of access to percutaneous valve interventions: EAPCI initiatives for patients and health care professionals
28 Nov 2022 – From PCR London Valves 2022
Consul this session if you want to understand current unmet needs in the field of transcatheter valve intervention, to appraise the impact of the Valve for Life initiative on adoption of TAVI across Europe, and to hear about the new EAPCI Core Curriculum for training in...
Rapid-fire abstracts: Session 7
28 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of abstracts presented during PCR LV 2022: contemporary outcome of high surgical risk mitral regurgitation, quantitative flow ratio vs. FFR for coronary functional evaluation in patients undergoing TAVI, videodensitometric quantification of paravalvular leak after implantation of the new Myval-Octacor,...
The impact of the first transcatheter heart valve on the lifetime management of patients with aortic stenosis
18 May 2022 – From EUROPCR 2022
This session from EuroPCR 2022 will help you understand how the first bioprosthetic aortic valve may affect long-term outcomes of patients with aortic stenosis. Learn how to optimise their lifetime management and how to refine procedural steps during TAVI.
How to decrease operator dependence on vessel opacification during PCI? A crash course on ultra-low contrast coronary interventions
17 May 2022 – From EuroPCR 2022
Watch this EuroPCR 2022 session to become aware of the importance of relying on less contrast injections to guide PCI in complex patients, to learn what skills are required and tools available to perform ultra-low contrast coronary interventions, and to share and discuss such a recorded intervention from...
Sirolimus coated balloon and coronary artery disease: expanding the treatment indications
17 May 2022 – From EuroPCR 2022
Through a case presentation, as well as upcoming studies and rationale for the Food and Drug Administration, the aim of this EuroPCR 2022 session is to help you answer the following questions: how can the use of a sirolimus-coated DCB be expanded in new and challenging treatment indications? Why is...
Lifetime management of patients with severe aortic stenosis - Securing long-term benefits
17 May 2022 – From EuroPCR 2022
Watching this EuroPCR 2022 session on lifetime management of patients with aortic stenosis will help you understand the importance of the heart team in patient specific treatment and how procedural refinement may optimise long-term outcomes.
